Cystic Fibrosis-Docosahexaenoic Acid Study
The Use of Formula Fortified with Docosahexaenoic Acid (DHA) in Infants with Cystic Fibrosis (CF)
Protocol ID
04.10.037
Protocol Description
The goal of this research is to see if the diet fed to infants in the first year of life affects the course of their cystic fibrosis (CF) disease. At this time nobody knows if changes in the diet make any difference in how sick people with CF are, but there is some evidence that certain fats in the diet may be important for children with CF. It is the goal of this research to see if adding small amounts of these fats to an infant’s diet will help children with CF.
Eligibility Criteria
Patients with cystic fibrosis (CF)
Primary Investigator(s)
- Joan DeCelie Germana, MD